Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples